Loading... please wait

The Horizon Prize – MIT Solve Pitch Competition Winner Announcement

Speakers:

Holly Copeland, Executive Director, CSR, Sustainability & Impact, Horizon Therapeutics
Rachael Drew, Portfolio Lead, MIT Solve

 

with Patron Programming Sponsor 

2560px Horizon Therapeutics logo.svg - The Horizon Prize - MIT Solve Pitch Competition Winner Announcement

“The Horizon Prize is the first and only global prize focused solely on rare disease.”

– Rachael Drew

“This year we have decided to award a second Horizon prize.” 

– Holly Copeland

Key takeaways & next steps:

  • Vula Mobile was announced as the winner of the 2023 Horizon Prize for their mobile platform connecting community health workers with sickle cell disease specialists in Northern Ghana. This innovation prioritizes treatments, reduces diagnostic journeys, and minimizes carbon emissions. 
  • The judges of the 2023 Horizon Prize decided to award a second Horizon prize in addition to the main winner. The second awardee, MendelScan, was recognized for their artificial intelligence (AI)-based technology that identifies patients with undiagnosed rare diseases through electronic health records. 
  • The Horizon Prize is a global competition created in 2021 to seek tech-based solutions for rare diseases. It aims to speed up the diagnostic journey and improve the quality of life for patients and caregivers dealing with rare diseases. It also focuses on addressing the environmental impact of the rare disease healthcare space. The healthcare industry has a substantial carbon footprint, and inefficiencies in biomedical research funding are detrimental to rare disease patients.

Copyright © 2024 Concordia.

All rights reserved. Concordia is a registered 501(c)(3) nonprofit, nonpartisan organization.